Ads
related to: CLDX
Search results
Wall Street Analysts Believe Celldex (CLDX) Could Rally 67.77%: Here's is How to Trade
Zacks via Yahoo Finance· 1 day agoThe consensus price target hints at a 67.8% upside potential for Celldex (CLDX). While empirical...
Celldex (CLDX) Surges 9%: Is This an Indication of Further Gains?
Zacks via Yahoo Finance· 2 years agoCelldex (CLDX) was a big mover last session on higher-than-average trading volume. The latest trend...
Celldex Makes A Bullish Move As It Looks To Take On Regeneron, Sanofi
Investor's Business Daily· 6 months agoCelldex Therapeutics could rival a key Regeneron Pharmaceuticals drug, an analyst said Monday as...
Celldex (CLDX) Down on Interim Data From Phase Ib Study in CSU
Zacks via Yahoo Finance· 2 years agoCelldex (CLDX) posts interim data from the phase Ib study evaluating barzolvolimab in patients with...
Earnings Preview: Celldex Therapeutics (CLDX) Q3 Earnings Expected to Decline
Zacks via Yahoo Finance· 2 years agoCelldex (CLDX) doesn't possess the right combination of the two key ingredients for a likely...
Celldex Therapeutics (CLDX) Reports Q3 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 2 years agoCelldex (CLDX) delivered earnings and revenue surprises of 0% and 62.80%, respectively, for the...
Celldex Therapeutics Skids As It Takes On A Blockbuster Roche, Novartis Drug
Investor's Business Daily· 2 years agoCelldex Therapeutics took aim at Roche and Novartis' blockbuster hives treatment on Friday with a...
Read How Cantor Views Celldex Therapeutics' Barzolvolimab Data
Benzinga via Yahoo Finance· 2 years agoCelldex Therapeutics Inc's (NASDAQ: CLDX) shares closed almost 16% down on Friday after releasing...
Celldex (CLDX) Initiates Phase II Chronic Skin Disorder Study
Zacks via Yahoo Finance· 2 years agoCelldex (CLDX) initiates dosing in a mid-stage study designed to evaluate its antibody candidate,...
Celldex Therapeutics First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Simply Wall St. via Yahoo Finance· 3 days agoCelldex Therapeutics (NASDAQ:CLDX) First Quarter 2024 Results Key Financial Results Net loss:...